Alloy Therapeutics
Growth Stage
BETA - Reg D
Better medicine, together
Analytics
Platform
OurCrowd
Start Date
03/10/2021
Close Date
03/19/2021
Min. Goal
$10,000
Max. Goal
$1,120,000
Min. Investment
$10,000
Security Type
Equity - Common
Funding Type
RegD 506(c)
Pre-Money Valuation
$450,000,000
Location
Waltham, Massachusetts
Industry
Business Services, Software, & Applications
Tech Sector
Medtech
Alloy Therapeutics, with a valuation of $450 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company has developed a platform that enables collaboration among scientists and democratizes access to foundational drug discovery platforms. The aim of the business is to make drug discovery and creation easier and more efficient. Alloy Therapeutics empowers drug discovery across six biologic modalities, including antibodies, TCRS, genetic medicines, peptides, cell therapies, and delivery. Errik Anderson founded Alloy Therapeutics in 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,120,000. The campaign proceeds will be used for growth and expansion.
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.